Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1945765
                    [Title] => Dengvaxia appeal rejected, but options open
                    [Summary] => The Department of Health (DOH) has rejected the appeal of pharmaceutical company Sanofi Pasteur to allow Dengvaxia into the local market due to failure to secure requirements.
                    [DatePublished] => 2019-08-23 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804856
                    [AuthorName] => Mayen Jaymalin
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2019/08/22/gen2-dengvaxia-sanofi_2019-08-22_23-26-01161_thumbnail.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 1945520
                    [Title] => DOH swats down Sanofi appeal to lift Dengvaxia ban
                    [Summary] => The Department of Health denied the appeal of pharmaceutical firm Sanofi Pasteur to lift the ban on Dengvaxia—the controversial vaccine the company said would protect against dengue.  
                    [DatePublished] => 2019-08-22 15:02:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2019/08/22/gen2-dengvaxia-kj-rosales2019-08-0300-01-31_2019-08-22_14-44-50553_thumbnail.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 1939727
                    [Title] => Rise in dengue, measles cases underline value of vaccines
                    [Summary] => The Philippines is facing two public health crises in 2019—a simmering measles outbreak and the soaring number of dengue cases.


                    [DatePublished] => 2019-08-01 12:07:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1805246
                    [AuthorName] => Gaea Katreena Cabico
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2019/08/01/110219vaccine03kjrosales_2019-08-01_11-48-19125_thumbnail.jpg
                )

            [3] => Array
                (
                    [ArticleID] => 1895030
                    [Title] => Sanofi Pasteur appeals Philippines revocation of Dengvaxia’s certificate of product registration
                    [Summary] => With the revocation of Dengvaxia, it is now unlawful to import, sell or distribute the said products.
                    [DatePublished] => 2019-02-19 18:32:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2019/02/19/dengvaxia-vaccines_2019-02-19_18-14-38826_thumbnail.jpg
                )

            [4] => Array
                (
                    [ArticleID] => 1865867
                    [Title] => DOJ set to release Dengvaxia probe results
                    [Summary] => Families of schoolchildren who died allegedly due to the controversial Dengvaxia vaccine may soon find an answer to their cry for justice.
                    [DatePublished] => 2018-11-05 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804827
                    [AuthorName] => Edu Punay
                    [SectionName] => Nation
                    [SectionUrl] => nation
                    [URL] => http://media.philstar.com/images/articles/nat2-families-dengvaxia-victim_2018-11-04_20-11-25653_thumbnail.jpg
                )

            [5] => Array
                (
                    [ArticleID] => 1862098
                    [Title] => Dengvaxia seen to get EU accreditation
                    [Summary] => Despite the controversy in the Philippines, Dengvaxia has moved a step closer to becoming the first accredited vaccine against dengue in the European Union (EU).
                    [DatePublished] => 2018-10-22 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804761
                    [AuthorName] => Helen Flores
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => http://media.philstar.com/images/articles/gen4-dengvaxia-box-ap_2018-10-21_22-21-29277_thumbnail.jpg
                )

            [6] => Array
                (
                    [ArticleID] => 1849092
                    [Title] => Senate approves  P1.16-billion supplemental budget for dengue assistance
                    [Summary] => The Senate has approved on third and final reading the P1.161-billion supplemental budget for assistance to people injected with the controversial Dengvaxia vaccine.
                    [DatePublished] => 2018-09-06 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804867
                    [AuthorName] => Marvin Sy
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => http://media.philstar.com/images/articles/gen11-house-senate-geremy-pintolo_2018-09-05_22-25-37995_thumbnail.jpg
                )

            [7] => Array
                (
                    [ArticleID] => 1847066
                    [Title] => ‘Sanofi’s P1.16-billion refund should be for Dengvaxia kids’
                    [Summary] => Health Secretary Francisco Duque III urged the Senate yesterday to pass a supplemental budget earmarking the P1.16 billion returned by pharmaceutical firm Sanofi Pasteur to assist children vaccinated with Dengvaxia.
                    [DatePublished] => 2018-08-30 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804896
                    [AuthorName] => Sheila Crisostomo
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => http://media.philstar.com/images/articles/gen7-francisco-duque-boy-santos_2018-08-29_22-19-57395_thumbnail.jpg
                )

            [8] => Array
                (
                    [ArticleID] => 1825088
                    [Title] => DOH not resuming Dengvaxia program
                    [Summary] => The Department of Health is unlikely to resume the anti-dengue immunization campaign using the controversial Dengvaxia vaccine even if the drug provides protection to people who have been previously infected with the mosquito-borne disease.
                    [DatePublished] => 2018-06-16 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804856
                    [AuthorName] => Mayen Jaymalin
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => http://media.philstar.com/images/articles/gen7-dengvaxia-box_2018-06-15_22-14-43_thumbnail.jpg
                )

            [9] => Array
                (
                    [ArticleID] => 1822343
                    [Title] => DOH urged to demand P3-billion refund from Dengvaxia maker
                    [Summary] => Health officials have been asked to demand P3 billion in full refund from French pharmaceutical giant Sanofi Pasteur for the controversial Dengvaxia vaccine.
                    [DatePublished] => 2018-06-07 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804863
                    [AuthorName] => Jess Diaz
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => http://media.philstar.com/images/articles/gen9-sanofi-pasteur-officials_2018-06-06_23-05-52690_thumbnail.jpg
                )

        )

)

Sanofi Pasteur

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1945765
                    [Title] => Dengvaxia appeal rejected, but options open
                    [Summary] => The Department of Health (DOH) has rejected the appeal of pharmaceutical company Sanofi Pasteur to allow Dengvaxia into the local market due to failure to secure requirements.
                    [DatePublished] => 2019-08-23 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804856
                    [AuthorName] => Mayen Jaymalin
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2019/08/22/gen2-dengvaxia-sanofi_2019-08-22_23-26-01161_thumbnail.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 1945520
                    [Title] => DOH swats down Sanofi appeal to lift Dengvaxia ban
                    [Summary] => The Department of Health denied the appeal of pharmaceutical firm Sanofi Pasteur to lift the ban on Dengvaxia—the controversial vaccine the company said would protect against dengue.  
                    [DatePublished] => 2019-08-22 15:02:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2019/08/22/gen2-dengvaxia-kj-rosales2019-08-0300-01-31_2019-08-22_14-44-50553_thumbnail.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 1939727
                    [Title] => Rise in dengue, measles cases underline value of vaccines
                    [Summary] => The Philippines is facing two public health crises in 2019—a simmering measles outbreak and the soaring number of dengue cases.


                    [DatePublished] => 2019-08-01 12:07:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1805246
                    [AuthorName] => Gaea Katreena Cabico
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2019/08/01/110219vaccine03kjrosales_2019-08-01_11-48-19125_thumbnail.jpg
                )

            [3] => Array
                (
                    [ArticleID] => 1895030
                    [Title] => Sanofi Pasteur appeals Philippines revocation of Dengvaxia’s certificate of product registration
                    [Summary] => With the revocation of Dengvaxia, it is now unlawful to import, sell or distribute the said products.
                    [DatePublished] => 2019-02-19 18:32:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2019/02/19/dengvaxia-vaccines_2019-02-19_18-14-38826_thumbnail.jpg
                )

            [4] => Array
                (
                    [ArticleID] => 1865867
                    [Title] => DOJ set to release Dengvaxia probe results
                    [Summary] => Families of schoolchildren who died allegedly due to the controversial Dengvaxia vaccine may soon find an answer to their cry for justice.
                    [DatePublished] => 2018-11-05 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804827
                    [AuthorName] => Edu Punay
                    [SectionName] => Nation
                    [SectionUrl] => nation
                    [URL] => http://media.philstar.com/images/articles/nat2-families-dengvaxia-victim_2018-11-04_20-11-25653_thumbnail.jpg
                )

            [5] => Array
                (
                    [ArticleID] => 1862098
                    [Title] => Dengvaxia seen to get EU accreditation
                    [Summary] => Despite the controversy in the Philippines, Dengvaxia has moved a step closer to becoming the first accredited vaccine against dengue in the European Union (EU).
                    [DatePublished] => 2018-10-22 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804761
                    [AuthorName] => Helen Flores
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => http://media.philstar.com/images/articles/gen4-dengvaxia-box-ap_2018-10-21_22-21-29277_thumbnail.jpg
                )

            [6] => Array
                (
                    [ArticleID] => 1849092
                    [Title] => Senate approves  P1.16-billion supplemental budget for dengue assistance
                    [Summary] => The Senate has approved on third and final reading the P1.161-billion supplemental budget for assistance to people injected with the controversial Dengvaxia vaccine.
                    [DatePublished] => 2018-09-06 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804867
                    [AuthorName] => Marvin Sy
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => http://media.philstar.com/images/articles/gen11-house-senate-geremy-pintolo_2018-09-05_22-25-37995_thumbnail.jpg
                )

            [7] => Array
                (
                    [ArticleID] => 1847066
                    [Title] => ‘Sanofi’s P1.16-billion refund should be for Dengvaxia kids’
                    [Summary] => Health Secretary Francisco Duque III urged the Senate yesterday to pass a supplemental budget earmarking the P1.16 billion returned by pharmaceutical firm Sanofi Pasteur to assist children vaccinated with Dengvaxia.
                    [DatePublished] => 2018-08-30 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804896
                    [AuthorName] => Sheila Crisostomo
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => http://media.philstar.com/images/articles/gen7-francisco-duque-boy-santos_2018-08-29_22-19-57395_thumbnail.jpg
                )

            [8] => Array
                (
                    [ArticleID] => 1825088
                    [Title] => DOH not resuming Dengvaxia program
                    [Summary] => The Department of Health is unlikely to resume the anti-dengue immunization campaign using the controversial Dengvaxia vaccine even if the drug provides protection to people who have been previously infected with the mosquito-borne disease.
                    [DatePublished] => 2018-06-16 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804856
                    [AuthorName] => Mayen Jaymalin
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => http://media.philstar.com/images/articles/gen7-dengvaxia-box_2018-06-15_22-14-43_thumbnail.jpg
                )

            [9] => Array
                (
                    [ArticleID] => 1822343
                    [Title] => DOH urged to demand P3-billion refund from Dengvaxia maker
                    [Summary] => Health officials have been asked to demand P3 billion in full refund from French pharmaceutical giant Sanofi Pasteur for the controversial Dengvaxia vaccine.
                    [DatePublished] => 2018-06-07 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804863
                    [AuthorName] => Jess Diaz
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => http://media.philstar.com/images/articles/gen9-sanofi-pasteur-officials_2018-06-06_23-05-52690_thumbnail.jpg
                )

        )

)

abtest

Dengvaxia appeal rejected, but options open

By Mayen Jaymalin | August 23, 2019 - 12:00am

The Department of Health (DOH) has rejected the appeal of pharmaceutical company Sanofi Pasteur to allow Dengvaxia into the...

Headlines

DOH swats down Sanofi appeal to lift Dengvaxia ban

August 22, 2019 - 3:02pm

The Department of Health denied the appeal of pharmaceutical firm Sanofi Pasteur to lift the ban on Dengvaxia—the controversial...

Headlines

Rise in dengue, measles cases underline value of vaccines

By Gaea Katreena Cabico | August 1, 2019 - 12:07pm

The Philippines is facing two public health crises in 2019—a simmering measles outbreak and the soaring number of dengue...

Headlines

Sanofi Pasteur appeals Philippines revocation of Dengvaxia’s certificate of product registration

February 19, 2019 - 6:32pm

With the revocation of Dengvaxia, it is now unlawful to import, sell or distribute the said products.

Headlines

DOJ set to release Dengvaxia probe results

By Edu Punay | November 5, 2018 - 12:00am

Families of schoolchildren who died allegedly due to the controversial Dengvaxia vaccine may soon find an answer to their...

Nation

Dengvaxia seen to get EU accreditation

By Helen Flores | October 22, 2018 - 12:00am

Despite the controversy in the Philippines, Dengvaxia has moved a step closer to becoming the first accredited vaccine against...

Headlines

Senate approves P1.16-billion supplemental budget for dengue assistance

By Marvin Sy | September 6, 2018 - 12:00am

The Senate has approved on third and final reading the P1.161-billion supplemental budget for assistance to people injected...

Headlines

‘Sanofi’s P1.16-billion refund should be for Dengvaxia kids’

By Sheila Crisostomo | August 30, 2018 - 12:00am

Health Secretary Francisco Duque III urged the Senate yesterday to pass a supplemental budget earmarking the P1.16 billion...

Headlines

DOH not resuming Dengvaxia program

By Mayen Jaymalin | June 16, 2018 - 12:00am

The Department of Health is unlikely to resume the anti-dengue immunization campaign using the controversial Dengvaxia vaccine...

Headlines

DOH urged to demand P3-billion refund from Dengvaxia maker

By Jess Diaz | June 7, 2018 - 12:00am

Health officials have been asked to demand P3 billion in full refund from French pharmaceutical giant Sanofi Pasteur for the...

Headlines